We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BIOG market cap is 277.13M. The company's latest EPS is GBP 2.3796 and P/E is 3.68.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 68.94M | 225.51M | -194.22M | -32.42M | 80.35M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 60.9M | 200.43M | -202.42M | -41.3M | 74.6M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 401.19M | 649.53M | 427.45M | 360.51M | 411.42M |
| Total Liabilities | 35.62M | 48.07M | 33.24M | 30.22M | 50.11M |
| Total Equity | 365.57M | 601.47M | 394.21M | 330.29M | 361.31M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -3.77M | -5.67M | -12.14M | -5.89M | -4.24M |
| Investing | 90.93M | -25.55M | 13.03M | 45.69M | 22.34M |
| Financing | -87.17M | 32.73M | -2.39M | -37.03M | -18.74M |
| Market Cap | 277.13M |
| Price to Earnings Ratio | 3.68 |
| Price to Sales Ratio | 3.41 |
| Price to Cash Ratio | 128.68 |
| Price to Book Ratio | 0.76 |
| Dividend Yield | - |
| Shares Outstanding | 31.35M |
| Average Volume (1 week) | 43.59k |
| Average Volume (1 Month) | 82.92k |
| 52 Week Change | -0.34% |
| 52 Week High | 1,068.00 |
| 52 Week Low | 845.00 |
| Spread (Intraday) | 6 (0.68%) |
| Company Name | Biotech Growth Trust (the) Plc |
| Address |
one wood street london EC2V 7WS |
| Website | https://www.biotechgt.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
